OXB announces date for Capital Markets Day and participation in upcoming investor conferencesOxford, UK – 3 March 2026: OXB (LSE: OXB), a global ...

Vector and Nammo Defense Systems partner to produce NDAA-compliant, kinetically-integrated UAS platforms for small-drone battlefield deployment.

Amsbio now offers a ready-to-use range of lentiviral particles designed to deliver target genes into virtually any mammalian cell type, both dividing and non-dividing, in vitro and in vivo. These ...

The MarketWatch News Department was not involved in the creation of this content. GERMANTOWN, MD AND CHICAGO, IL / ACCESS Newswire / December 16, 2025 / uBriGene Biosciences, a leading global ...

LVV Turbo™ 293TH High-Productivity Suspension Cell Line Engineered for exceptional lentiviral productivity, the 293TH line consistently delivers high titers, producing up to five times higher ...

Brianna Jayanthi, PhD, is a principal scientist at Asimov, where she has helped lead the development of next-generation cell lines for viral vector manufacturing. Since joining Asimov in 2019, she has ...

VectorBuilder pioneers cutting-edge innovation for AAV gene delivery, with a one-stop solution supporting programs from research to early discovery to clinical development. Its proprietary technology ...

First commercially available cell culture solution for HEK293 cells and perfusion -– optimized for high cell density (HCD), intensified processes and perfusion cultures Additional capabilities for ...

Discover how Miltenyi Bioindustry’s powerful lentiviral vector (LVV) platform enabled a clinical-stage biotech company to move from contract signing to GMP production in just five months. Designed for ...